 The study will assess the effect of bivalirudin administration during primary percutaneous coronary intervention PPCI and for 4 hours h afterwards, looking at contrast enhanced cardiac magnetic resonance imaging CMR assessed infarct size and on circulating markers of thrombosis and cell injury in subjects treated with PPCI for a large myocardial infarction MI. 